𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial

✍ Scribed by Yokoyama, S.; Takahashi, S.; Kawakami, Y.; Hayes, C. N.; Kohno, H.; Kohno, H.; Tsuji, K.; Aisaka, Y.; Kira, S.; Yamashina, K.; Nonaka, M.; Moriya, T.; Kitamoto, M.; Aimitsu, S.; Nakanishi, T.; Kawakami, H.; Chayama, K.

Book ID
126273791
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
170 KB
Volume
21
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized controlled trial of pegylated
Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6
✍ Khoa D. Lam; Huy N. Trinh; Son T. Do; Thuan T. Nguyen; Ruel T. Garcia; Tuan Nguy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 246 KB πŸ‘ 2 views

Hepatitis C virus (HCV) genotype is an important criteria in determining duration of therapy and predictor of sustained virologic response (SVR) to pegylated interferon (PEG IFN) and ribavirin (RBV) therapy. Optimal duration of therapy for patients with HCV genotype 6 is not known. We conducted a mu